{"cluster": 36, "subcluster": 35, "abstract_summ": "DPP4, originally known as the lymphocyte cell surface protein CD26, is widely expressed in many types of immune cells including CD4(+) and CD8(+) T cells, B cells, NK cells, dendritic cells, and macrophages; and regulate the functions of these cells.DPP-4 is expressed by endothelial and epithelial cells, the kidney, intestine and cells of the immune system; it has a broad spectrum of biological functions in immune regulation, cancer biology and glucose metabolism.Nevertheless, this observation may rise the question on whether DPP4 is directly involved in SARS\u2010CoV\u20102 cell adhesion/virulence, and whether DPP4 inhibition might be a therapeutic strategy for preventing infection.In order to identify the key vitamin D target genes involved in these processes, transcriptome-wide datasets were compared, which were obtained from a human monocytic cell line (THP-1) and peripheral blood mononuclear cells (PBMCs) treated in vitro by 1,25(OH)(2)D(3), filtered using different approaches, as well as from PBMCs of individuals supplemented with a vitamin D(3) bolus.METHODS: Virus binds to the cell surface receptor ACE2; indeed, recent evidences suggested that SARS\u2013CoV-2 may be using as co-receptor, when entering the cells, the same one used by MERS\u2013Co-V, namely the DPP4/CD26 receptor.", "title_summ": "Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19Iron-rich air pollution nanoparticles: an unrecognised environmental risk factor for myocardial mitochondrial dysfunction and cardiac oxidative stressDipeptidyl peptidase 4 inhibitors and their potential immune modulatory functionsDPP4 inhibition: preventing SARS\u2010CoV\u20102 infection and/or progression of COVID\u201019?Enigmatic Histamine Receptor H(4) for Potential Treatment of Multiple Inflammatory, Autoimmune, and Related DiseasesKey Vitamin D Target Genes with Functions in the Immune SystemThe emerging role of dipeptidyl-peptidase-4 as a therapeutic target in lung disease.Consideration of Pannexin 1 channels in COVID-19 pathology and treatment.", "title_abstract_phrases": "DPP4, originally known as the lymphocyte cell surface protein CD26, is widely expressed in many types of immune cells including CD4(+) and CD8(+) T cells, B cells, NK cells, dendritic cells, and macrophages; and regulate the functions of these cells.In order to identify the key vitamin D target genes involved in these processes, transcriptome-wide datasets were compared, which were obtained from a human monocytic cell line (THP-1) and peripheral blood mononuclear cells (PBMCs) treated in vitro by 1,25(OH)(2)D(3), filtered using different approaches, as well as from PBMCs of individuals supplemented with a vitamin D(3) bolus.DPP-4 is expressed by endothelial and epithelial cells, the kidney, intestine and cells of the immune system; it has a broad spectrum of biological functions in immune regulation, cancer biology and glucose metabolism.Nevertheless, this observation may rise the question on whether DPP4 is directly involved in SARS\u2010CoV\u20102 cell adhesion/virulence, and whether DPP4 inhibition might be a therapeutic strategy for preventing infection.Further clinical studies will be necessitated to fully evaluate the administration of DPP4is in diabetic patients with or without immune diseases."}